Keros Therapeutics, Inc. (KROS)
11.02
+0.03
(+0.27%)
USD |
NASDAQ |
Mar 13, 16:00
11.00
-0.02
(-0.14%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 217.29M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.512B |
| MannKind Corp. | 853.44M |
| Sarepta Therapeutics, Inc. | 1.722B |
| PTC Therapeutics, Inc. | 5.338B |
| Insmed, Inc. | 30.07B |
Market Cap Related Metrics
| PE Ratio | 6.051 |
| PS Ratio | 1.687 |
| Price to Book Value | 0.7168 |
| Price to Free Cash Flow | 3.886 |
| Price | 11.02 |
| Earnings Yield | 16.53% |
| Operating PE Ratio | 6.086 |
| Normalized PE Ratio | 6.044 |